Should Value Investors Buy Cardinal Health (CAH) Stock?
Werte in diesem Artikel
While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With this in mind, we are always looking at value, growth, and momentum trends to discover great companies.Of these, value investing is easily one of the most popular ways to find great stocks in any market environment. Value investors rely on traditional forms of analysis on key valuation metrics to find stocks that they believe are undervalued, leaving room for profits.Zacks has developed the innovative Style Scores system to highlight stocks with specific traits. For example, value investors will be interested in stocks with great grades in the "Value" category. When paired with a high Zacks Rank, "A" grades in the Value category are among the strongest value stocks on the market today.One company value investors might notice is Cardinal Health (CAH). CAH is currently sporting a Zacks Rank of #2 (Buy), as well as an A grade for Value. The stock has a Forward P/E ratio of 15.26. This compares to its industry's average Forward P/E of 16.92. Over the past year, CAH's Forward P/E has been as high as 15.66 and as low as 12.37, with a median of 14.27.CAH is also sporting a PEG ratio of 1.60. This popular figure is similar to the widely-used P/E ratio, but the PEG ratio also considers a company's expected EPS growth rate. CAH's PEG compares to its industry's average PEG of 1.86. Over the last 12 months, CAH's PEG has been as high as 1.61 and as low as 0.91, with a median of 1.39.Finally, investors will want to recognize that CAH has a P/CF ratio of 15.74. This metric focuses on a firm's operating cash flow and is often used to find stocks that are undervalued based on the strength of their cash outlook. This stock's P/CF looks attractive against its industry's average P/CF of 17.83. Within the past 12 months, CAH's P/CF has been as high as 20.81 and as low as 13.22, with a median of 15.27.These are just a handful of the figures considered in Cardinal Health's great Value grade. Still, they help show that the stock is likely being undervalued at the moment. Add this to the strength of its earnings outlook, and we can clearly see that CAH is an impressive value stock right now.Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 256 positions with double- and triple-digit gains in 2024 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Cardinal Health, Inc. (CAH): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Cardinal Health und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.
Ausgewählte Hebelprodukte auf Cardinal
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Cardinal
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|---|---|---|
Für diesen Basiswert sind keine Produkte mit dem gewählten Hebel verfügbar |
Name | Hebel | KO | Emittent |
---|---|---|---|
Für diesen Basiswert sind keine Produkte mit dem gewählten Hebel verfügbar |
Quelle: Zacks
Nachrichten zu Cardinal Health Inc.
Analysen zu Cardinal Health Inc.
Datum | Rating | Analyst | |
---|---|---|---|
08.03.2018 | Cardinal Health Equal Weight | Barclays Capital | |
04.12.2017 | Cardinal Health Hold | Deutsche Bank AG | |
19.09.2017 | Cardinal Health Sector Perform | RBC Capital Markets | |
28.04.2017 | Cardinal Health Neutral | Tigress Financial | |
04.04.2017 | Cardinal Health Hold | Needham & Company, LLC |
Datum | Rating | Analyst | |
---|---|---|---|
03.11.2015 | Cardinal Health Buy | UBS AG | |
03.11.2015 | Cardinal Health Outperform | FBR Capital | |
09.06.2015 | Cardinal Health Buy | UBS AG | |
10.03.2015 | Cardinal Health Outperform | FBR Capital | |
04.03.2015 | Cardinal Health Outperform | RBC Capital Markets |
Datum | Rating | Analyst | |
---|---|---|---|
08.03.2018 | Cardinal Health Equal Weight | Barclays Capital | |
04.12.2017 | Cardinal Health Hold | Deutsche Bank AG | |
19.09.2017 | Cardinal Health Sector Perform | RBC Capital Markets | |
28.04.2017 | Cardinal Health Neutral | Tigress Financial | |
04.04.2017 | Cardinal Health Hold | Needham & Company, LLC |
Datum | Rating | Analyst | |
---|---|---|---|
Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Cardinal Health Inc. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen